Rhenman & Partners Asset Management AB
Position in ABT — Abbott Laboratories
CIK 1599882
Stockholm, V7
Position in ABT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,499,040
-$1,694,050 QoQ
Shares Held
112,000
+13.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Rhenman & Partners Asset Management AB holds $125,056,277 across 12 Medical Devices names. ABT ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
625,000 | $39,218,750 | |
| 2 | SYK |
Stryker Corp
|
47,800 | $15,706,602 | |
| 3 | EW |
Edwards Lifesciences Corp
|
163,000 | $13,053,040 | |
| 4 | PRCT |
PROCEPT BioRobotics Corp
|
475,000 | $11,879,750 | |
| 5 | ABT |
Abbott Laboratories
This page
|
112,000 | $11,499,040 | |
| 6 | LIVN |
LivaNova PLC
|
155,000 | $9,851,800 | |
| 7 | GKOS |
GLAUKOS Corp
|
84,000 | $9,043,440 | |
| 8 | MDT |
Medtronic plc
|
90,000 | $7,798,500 |
All Filings in ABT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,499,040 | 112,000 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $13,193,090 | 98,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,956,585 | 58,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,897,800 | 52,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $14,478,080 | 128,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,391,350 | 135,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $15,066,950 | 145,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,027,100 | 185,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $22,564,350 | 205,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $25,343,223 | 261,675 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $27,145,980 | 249,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $18,733,100 | 185,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,845,430 | 117,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $11,320,920 | 117,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,470,500 | 170,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,652,400 | 90,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,074,000 | 100,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $24,334,780 | 206,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $28,982,500 | 250,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $32,956,000 | 275,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $16,423,500 | 150,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $22,310,150 | 205,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $16,914,550 | 185,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $13,414,700 | 170,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||